✦ LIBER ✦

Trastuzumab plus intravenous or oral vinorelbine in chemonaive patients with HER-2 overexpressing metastatic breast cancer – final results of an extended phase II trial

✍ Scribed by G. Bernardo; R. Palumbo; A. Bernardo; C. Teragni; G. Poggi; A. Delmonte; A. Amatu; M. Frascaroli; I. Jedrychowska; M. Strada

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5076 POSTER Phase II Study of Vinorelbin

✍ Kwon, H.; Oh, S.Y.; Kim, S.H.; Lee, S.; Lee, J.H.; Kim, H.J. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase I trial of oral mTOR inhibitor eve

✍ Guy Jerusalem; Angelica Fasolo; Veronique Dieras; Fatima Cardoso; Jonas Bergh; L 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 326 KB

Intravenous or Oral Vinorelbine Plus Cap

✍ Maria Rosa Strada; Raffaella Palumbo; Antonio Bernardo; Alberto Riccardi; Cristi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 423 KB

Phase II Trial of Gemcitabine/Carboplati

✍ David Loesch; Lina Asmar; Kristi McIntyre; Lisa Doane; Michael Monticelli; Devch 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB

A Phase I/II Trial of Trastuzumab and Ge

✍ Stacy L. Moulder; Carlos L. Arteaga 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

Phase II Trial of Weekly Docetaxel, Vino

✍ Jeffrey R. Infante; Denise A. Yardley; Howard A. Burris III; F. Anthony Greco; C 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB